Literature DB >> 15214034

Depending on their maturation state, splenic dendritic cells induce the differentiation of CD4(+) T lymphocytes into memory and/or effector cells in vivo.

Magali de Heusch1, Guillaume Oldenhove, Jacques Urbain, Kris Thielemans, Charlie Maliszewski, Oberdan Leo, Muriel Moser.   

Abstract

There is increasing evidence that dendritic cells (DC) display opposite functions in the immune system, as they may induce immunity or tolerance depending on intrinsic and environmental factors. In mice, adoptive transfer of mature DC pulsed extracorporeally with antigen induces the development of antigen-specific Th1- and Th2-type CD4(+) cells. In this work, we compared the adjuvant properties of immature (freshly isolated) and mature (cultured) splenic DC in vivo. Our data show that injection of either cell population induces the clonal expansion of CD4(+) T cells but that only mature DC trigger their differentiation into effector cells producing IFN-gamma. In contrast, transfer of immature DC provokes the development of intermediates in the differentiation process, similar to the central memory cells. These observations, together with data in the literature, suggest that DC may induce tolerance, memory, or immunity depending on their maturation state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15214034     DOI: 10.1002/eji.200424878

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  PD-L1 blockade improves immune dysfunction of spleen dendritic cells and T-cells in zymosan-induced multiple organs dysfunction syndromes.

Authors:  Qian Liu; Yi Lv; Min Zhao; Yiduo Jin; Jiangyang Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models.

Authors:  Uri Sela; Amir Sharabi; Molly Dayan; Rami Hershkoviz; Edna Mozes
Journal:  Immunology       Date:  2008-11-24       Impact factor: 7.397

3.  T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection.

Authors:  Karen Smith Korsholm; Rune V Petersen; Else Marie Agger; Peter Andersen
Journal:  Immunology       Date:  2009-07-14       Impact factor: 7.397

4.  Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors.

Authors:  Sayuri Yamazaki; Anthony J Bonito; Radek Spisek; Madhav Dhodapkar; Kayo Inaba; Ralph M Steinman
Journal:  Blood       Date:  2007-08-15       Impact factor: 22.113

5.  Role of biphasic changes in splenic dendritic cell activity in a mouse model of multiple organ dysfunction syndrome.

Authors:  Yi Lv; Qian Liu; Min Zhao; Yiduo Jin; Jiangyang Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

6.  Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities.

Authors:  Fouad Eddahri; Sébastien Denanglaire; Fabrice Bureau; Rosanne Spolski; Warren J Leonard; Oberdan Leo; Fabienne Andris
Journal:  Blood       Date:  2008-11-19       Impact factor: 22.113

7.  Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine.

Authors:  Igor Popov; Mu Li; Xiufen Zheng; Hongtao San; Xusheng Zhang; Thomas E Ichim; Motohiko Suzuki; Biao Feng; Costin Vladau; Robert Zhong; Bertha Garcia; Gill Strejan; Robert D Inman; Wei-Ping Min
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

8.  A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4+ and CD8+ T Cells.

Authors:  Angello R Retamal-Díaz; Alexis M Kalergis; Susan M Bueno; Pablo A González
Journal:  Front Immunol       Date:  2017-08-09       Impact factor: 7.561

9.  Fast Maturation of Splenic Dendritic Cells Upon TBI Is Associated With FLT3/FLT3L Signaling.

Authors:  Jin Zhang; Zhenghui Li; Akila Chandrasekar; Shun Li; Albert Ludolph; Tobias Maria Boeckers; Markus Huber-Lang; Francesco Roselli; Florian Olde Heuvel
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

10.  An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma.

Authors:  Sara Nava; Marta Dossena; Simona Pogliani; Serena Pellegatta; Carlo Antozzi; Fulvio Baggi; Cinzia Gellera; Bianca Pollo; Eugenio A Parati; Gaetano Finocchiaro; Simona Frigerio
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.